Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 510 | 152 | 970 | 356 |
| Cost of Goods | N/A | 1 | 302 | 286 | 5 |
| Gross Profit | N/A | 509 | -150 | 683 | 351 |
| Operating Expenses | 7,151 | 5,215 | 6,919 | 16,084 | 12,062 |
| Operating Income | -7,151 | -4,705 | -6,767 | -15,114 | -11,706 |
| Interest Expense | 416 | 826 | 1,314 | 294 | 227 |
| Other Income | -786 | 162 | 56 | -106 | 722 |
| Pre-tax Income | -8,353 | -5,370 | -8,025 | -15,515 | -11,211 |
| Income Tax | 24 | -111 | 256 | 798 | 825 |
| Net Income Continuous | -8,377 | -5,259 | -8,281 | -16,312 | -12,036 |
| Minority Interests | -468 | -356 | -493 | 111 | 803 |
| Net Income | $-7,909 | $-4,903 | $-7,788 | $-16,423 | $-12,839 |
| EPS Basic Total Ops | -0.39 | -0.42 | -1.80 | -5.19 | -5.10 |
| EPS Basic Continuous Ops | -0.42 | -0.45 | -1.91 | -5.15 | -4.80 |
| EPS Diluted Total Ops | -0.39 | -0.42 | -1.80 | -5.19 | -5.10 |
| EPS Diluted Continuous Ops | -0.42 | -0.45 | -1.91 | -5.15 | -4.80 |
| EPS Diluted Before Non-Recurring Items | -0.35 | -0.42 | -2.43 | -5.20 | -5.10 |
| EBITDA(a) | $-6,646 | $-4,504 | $-6,386 | $-15,091 | $-11,694 |